RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tsuyoshi Fujita to 2-Pyridinylmethylsulfinylbenzimidazoles

Back to Details
This is a "connection" page, showing publications Tsuyoshi Fujita has written about 2-Pyridinylmethylsulfinylbenzimidazoles.
Tsuyoshi Fujita
Connection Strength
0.095
2-Pyridinylmethylsulfinylbenzimidazoles
  1. Sanuki T, Fujita T, Kutsumi H, Hayakumo T, Yoshida S, Inokuchi H, Murakami M, Matsubara Y, Kuwayama H, Kawai T, Miyaji H, Fujisawa T, Terao S, Yamazaki Y, Azuma T. Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. J Gastroenterol. 2012 Nov; 47(11):1186-97.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support